Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Zhangjiang Hi-tech Park Sets Up $147 Million Life Science Fund

publication date: Apr 1, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

A 1 billion RMB ($147 million) fund has been established by the Zhangjiang Hi-tech Zone in Shanghai to support young life science companies. Called the Zhangjiang Biopharmaceutical Industry Fund, it will assist companies with biopharmaceutical, medical device, diagnostic reagent and traditional Chinese medicine products. To qualify, the projects need to be approved for clinical trials or production/marketing, or be about to enter the clinical investigation stage. More details...

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...